Who
Aaron Freidin
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Grail.
In numbers
- Trades disclosed
- 37
- Buys
- 0
- Sells
- 17
- Bought
- $0
- Sold
- $16.6M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 Jun 2024
- Last trade
- 5 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Oct 2026filed 7 Oct 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $3.5M23,619 at $146.39 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $164K1,779 at $92.26 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $169K1,800 at $93.92 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $49K521 at $95.00 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $164K1,779 at $92.26 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $169K1,800 at $93.92 | filing |
| 21 Sep 2026filed 23 Sep 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $49K521 at $95.00 | filing |
| 27 Aug 2026filed 31 Aug 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $672K7,900 at $85.01 | filing |
| 27 Aug 2026filed 31 Aug 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $672K7,900 at $85.01 | filing |
| 8 Apr 2026filed 9 Apr 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $2.3M45,806 at $49.92 | filing |
| 8 Apr 2026filed 9 Apr 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $2.3M45,806 at $49.92 | filing |
| 9 Mar 2026filed 9 Mar 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $115K2,407 at $47.93 | filing |
| 9 Mar 2026filed 9 Mar 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $3,97385 at $46.74 | filing |
| 9 Mar 2026filed 9 Mar 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $115K2,407 at $47.93 | filing |
| 9 Mar 2026filed 9 Mar 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $3,97385 at $46.74 | filing |
| 5 Mar 2026filed 9 Mar 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $35K655 at $53.01 | filing |
| 5 Mar 2026filed 9 Mar 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $35K655 at $53.01 | filing |
| 2 Mar 2026filed 3 Mar 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $458K9,135 at $50.09 | filing |
| 2 Mar 2026filed 3 Mar 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $23K438 at $51.86 | filing |
| 2 Mar 2026filed 3 Mar 2026 | GRAL GrailDiagnostics & Labs | SEC FORM 4 Sold | $458K9,135 at $50.09 | filing |
News
Grail CFO Aaron Freidin Sells 7,900 Shares for $672,000fool.com · 9 Sep 2026GRAIL (NASDAQ:GRAL) CEO Joshua Ofman Sells 20,000 Shares of StockGRAL · dailypolitical.com · 17 Oct 2026Jim Cramer Breaks Down the Stakes in Detail as GRAIL (GRAL) Awaits Its Next Big DecisionGRAL · insidermonkey.com · 10 Oct 2026
1 headline in the last 90 days name Aaron Freidin; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.